Amedeo Smart

Free Medical Literature Service


 

Amedeo

Autoimmune Disorders

  Free Subscription

Articles published in
Acta Neurol Scand
    September 2021
  1. KAUR H, Sureshbabu S, Mittal GK, Joseph M, et al
    Catastrophic health expenditure in patients with Guillain Barre syndrome: Retrospective study.
    Acta Neurol Scand. 2021 Sep 1. doi: 10.1111/ane.13523.
    >> Share

    August 2021
  2. MARIC G, Pekmezovic T, Tamas O, Veselinovic N, et al
    Impact of comorbidities on the disability progression in multiple sclerosis.
    Acta Neurol Scand. 2021 Aug 20. doi: 10.1111/ane.13516.
    >> Share

  3. TELJAS C, Bostrom I, Marrie RA, Landtblom AM, et al
    Validating the diagnosis of multiple sclerosis using Swedish administrative data in Varmland County.
    Acta Neurol Scand. 2021 Aug 6. doi: 10.1111/ane.13514.
    >> Share

    July 2021
  4. JOHANSSON K, Wasling P, Axelsson M
    Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsy.
    Acta Neurol Scand. 2021 Jul 19. doi: 10.1111/ane.13497.
    >> Share

    June 2021
  5. ZHUKOVSKY C, Herman S, Wiberg A, Cunningham JL, et al
    Urokinase, CX3CL1, CCL2, TRAIL and IL-18 induced by interferon-beta treatment.
    Acta Neurol Scand. 2021;143:602-607.
    >> Share

    May 2021
  6. LANDTBLOM AM, Berntsson SG, Bostrom I, Iacobaeus E, et al
    Multiple sclerosis and COVID-19: The Swedish experience.
    Acta Neurol Scand. 2021 May 24. doi: 10.1111/ane.13453.
    >> Share

  7. TARAKCI E, Tarakci D, Hajebrahimi F, Budak M, et al
    Supervised exercises versus telerehabilitation. Benefits for persons with multiple sclerosis.
    Acta Neurol Scand. 2021 May 7. doi: 10.1111/ane.13448.
    >> Share

    April 2021
  8. FEASEL CD, Sandroff BM, Motl RW
    Aerobic reserve capacity in multiple sclerosis-Preliminary evidence.
    Acta Neurol Scand. 2021 Apr 29. doi: 10.1111/ane.13441.
    >> Share

  9. SAIED Z, Rachdi A, Thamlaoui S, Nabli F, et al
    Myasthenia gravis and COVID-19: A case series and comparison with literature.
    Acta Neurol Scand. 2021 Apr 29. doi: 10.1111/ane.13440.
    >> Share

    March 2021
  10. DONSKOV AO, Vinge L, Axelsen SM, Andersen H, et al
    Overactive bladder in patients with myasthenia gravis-A cross-sectional population-based study.
    Acta Neurol Scand. 2021 Mar 27. doi: 10.1111/ane.13419.
    >> Share

  11. KAVALIUNAS A, Danylaite Karrenbauer V, Hillert J
    Socioeconomic consequences of multiple sclerosis-A systematic literature review.
    Acta Neurol Scand. 2021 Mar 22. doi: 10.1111/ane.13411.
    >> Share

    February 2021
  12. OLSSON A, Gustavsen S, Gisselo Lauridsen K, Chenoufi Hasselbalch I, et al
    Neutrophil-to-lymphocyte ratio and CRP as biomarkers in multiple sclerosis: A systematic review.
    Acta Neurol Scand. 2021 Feb 16. doi: 10.1111/ane.13401.
    >> Share

    December 2020
  13. TEKEOGLU A, Yeldan I, Ozdincler AR, Saip S, et al
    The efficiency of mirror therapy on drop foot in Multiple Sclerosis Patients.
    Acta Neurol Scand. 2020 Dec 3. doi: 10.1111/ane.13385.
    >> Share

  14. RYLTOFT AK, Al-Zuhairy A, Sindrup SH, Andersen H, et al
    Quality of life in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin.
    Acta Neurol Scand. 2020;142:637-640.
    >> Share

    November 2020
  15. NI G, Lin W, Cai X, Qin J, et al
    Associations between seizures and MRI in patients with anti-NMDAR encephalitis.
    Acta Neurol Scand. 2020;142:460-465.
    >> Share

  16. BORGSTROM M, Tisell A, Link H, Wilhelm E, et al
    Retinal thinning and brain atrophy in early MS and CIS.
    Acta Neurol Scand. 2020;142:418-427.
    >> Share

    September 2020
  17. TRIPATHI M, St AR, Ihtisham K, Garg A, et al
    Metabolic scoring in Autoimmune Epilepsy-Should APE scores be modified?
    Acta Neurol Scand. 2020 Sep 16. doi: 10.1111/ane.13346.
    >> Share

  18. CHESHMAVAR M, Mirmosayyeb O, Badihian N, Badihian S, et al
    Rituximab and glatiramer-acetate in secondary-progressive multiple sclerosis: A randomized-clinical trial.
    Acta Neurol Scand. 2020 Sep 8. doi: 10.1111/ane.13344.
    >> Share

    August 2020
  19. CHEN J, Shang W, Chen Y, Li Y, et al
    Thymomatous Myasthenia Gravis: 10-year Experience of a Single Center.
    Acta Neurol Scand. 2020 Aug 6. doi: 10.1111/ane.13332.
    >> Share

  20. WONG VT, So H, Lam TT, Yip RM, et al
    Myositis-specific autoantibodies and their clinical associations in idiopathic inflammatory myopathies.
    Acta Neurol Scand. 2020 Aug 6. doi: 10.1111/ane.13331.
    >> Share

  21. JONS D, Zetterberg H, Malmestrom C, Bergstrom T, et al
    Intrathecal immunoreactivity in people with or without previous infectious mononucleosis.
    Acta Neurol Scand. 2020;142:161-168.
    >> Share

    July 2020
  22. WANDELL P, Fredrikson S, Carlsson AC, Li X, et al
    Multiple sclerosis among first- and second-generation immigrant groups in Sweden.
    Acta Neurol Scand. 2020 Jul 10. doi: 10.1111/ane.13314.
    >> Share

  23. VECCHIO D, Varrasi C, Virgilio E, Spagarino A, et al
    Cannabinoids in multiple sclerosis: A neurophysiological analysis.
    Acta Neurol Scand. 2020 Jul 6. doi: 10.1111/ane.13313.
    >> Share

    June 2020
  24. LAHDENPERA S, Soilu-Hanninen M, Kuusisto HM, Atula S, et al
    Medication adherence/persistence among patients with active multiple sclerosis in Finland.
    Acta Neurol Scand. 2020 Jun 19. doi: 10.1111/ane.13301.
    >> Share

  25. NING P, Yang B, Yang X, Zhao Q, et al
    A nomogram to predict mechanical ventilation in Guillain-Barre syndrome patients.
    Acta Neurol Scand. 2020 Jun 4. doi: 10.1111/ane.13294.
    >> Share

  26. PIRTTISALO AL, Soilu-Hanninen M, Sumelahti ML, Krokki O, et al
    Changes in multiple sclerosis epidemiology in Finland over five decades.
    Acta Neurol Scand. 2020 Jun 4. doi: 10.1111/ane.13295.
    >> Share

  27. NEPAL G, Shing YK, Yadav JK, Rehrig JH, et al
    Efficacy and safety of rituximab in autoimmune encephalitis: a meta-analysis.
    Acta Neurol Scand. 2020 Jun 2. doi: 10.1111/ane.13291.
    >> Share

    May 2020
  28. MAMOEI S, Hvid LG, Boye Jensen H, Zijdewind I, et al
    Neurophysiological impairments in multiple sclerosis - central and peripheral motor pathways.
    Acta Neurol Scand. 2020 May 31. doi: 10.1111/ane.13289.
    >> Share

  29. ZANONI M, Orlandi E, Rossetti G, Turatti M, et al
    Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients.
    Acta Neurol Scand. 2020 May 20. doi: 10.1111/ane.13288.
    >> Share

  30. ZHU F, Shan W, Lv R, Li Z, et al
    Clinical characteristics of GAD 65 associated autoimmune encephalitis.
    Acta Neurol Scand. 2020 May 16. doi: 10.1111/ane.13281.
    >> Share

  31. COSTA ARPIN E, Naveiro Soneira J, Lema Bouzas M, Quintela AG, et al
    Epidemiology of multiple sclerosis IN Santiago de Compostela (Spain).
    Acta Neurol Scand. 2020 May 11. doi: 10.1111/ane.13265.
    >> Share

    April 2020
  32. CHOU CC, Huang MH, Lan WC, Kong SS, et al
    Prevalence and risk of thyroid diseases in myasthenia gravis.
    Acta Neurol Scand. 2020 Apr 23. doi: 10.1111/ane.13254.
    >> Share

    March 2020
  33. REYES S, Suarez S, Allen-Philbey K, Thomson A, et al
    The impact of social capital on patients with multiple sclerosis.
    Acta Neurol Scand. 2020 Mar 18. doi: 10.1111/ane.13244.
    >> Share

  34. LAAKSO SM, Hekali O, Kurdo G, Martola J, et al
    Trigeminal neuralgia in multiple sclerosis: prevalence and association with demyelination.
    Acta Neurol Scand. 2020 Mar 18. doi: 10.1111/ane.13243.
    >> Share

  35. LOTAN I, Benninger F, Hellmann MA, Sicsic C, et al
    Incidence of AChR -Ab positive myasthenia gravis in Israel: A population- based study.
    Acta Neurol Scand. 2020 Mar 7. doi: 10.1111/ane.13239.
    >> Share

  36. WILSKI M, Kocur P, Brola W, Tasiemski T, et al
    Psychological factors associated with self-management in multiple sclerosis.
    Acta Neurol Scand. 2020 Mar 2. doi: 10.1111/ane.13236.
    >> Share

  37. ZARGHAMI A, Nourmohammadi ST, Hojjati SMM
    Urbanization theory and socioeconomic changeover of multiple sclerosis in Iran.
    Acta Neurol Scand. 2020;141:256.
    >> Share

    February 2020
  38. RASMAN A
    Air pollution, a risk factor for multiple sclerosis?
    Acta Neurol Scand. 2020 Feb 25. doi: 10.1111/ane.13235.
    >> Share

    January 2020
  39. HELLGREN J, Risedal A, Kallen K
    Rituximab in multiple sclerosis at general hospital level.
    Acta Neurol Scand. 2020 Jan 28. doi: 10.1111/ane.13225.
    >> Share

  40. TURK BORU U, Boluk C, Tasdemir M, Gezer T, et al
    Air pollution, a possible risk factor for multiple sclerosis.
    Acta Neurol Scand. 2020 Jan 18. doi: 10.1111/ane.13223.
    >> Share

    December 2019
  41. MURTONEN A, Sumelahti ML
    Multiple sclerosis prevalence in 2000 and 2010 in Western Finland.
    Acta Neurol Scand. 2019 Dec 14. doi: 10.1111/ane.13203.
    >> Share

  42. LIU X, Zhang L, Chen C, Gong X, et al
    Long-term cognitive and neuropsychiatric outcomes in patients with anti-NMDAR encephalitis.
    Acta Neurol Scand. 2019;140:414-421.
    >> Share

    November 2019
  43. DJORDJEVIC G, Stojanov A, Bozovic I, Berisavac I, et al
    Six-month prospective study of quality of life in Guillain-Barre syndrome.
    Acta Neurol Scand. 2019 Nov 8. doi: 10.1111/ane.13195.
    >> Share

  44. WALLIS O, Bol Y, Kohler S, van Heugten C, et al
    Anxiety in multiple sclerosis is related to depressive symptoms and cognitive complaints.
    Acta Neurol Scand. 2019 Nov 6. doi: 10.1111/ane.13191.
    >> Share

  45. SCOTT TF, Diehl D, Elmalik W, Gettings EJ, et al
    Multiple sclerosis relapses contribute to long-term disability.
    Acta Neurol Scand. 2019;140:336-341.
    >> Share

    October 2019
  46. SMOLDERS J, Mimpen M, Oechtering J, Damoiseaux J, et al
    Vitamin D3 supplementation and neurofilament light chain in multiple sclerosis.
    Acta Neurol Scand. 2019 Oct 28. doi: 10.1111/ane.13185.
    >> Share

  47. ZETTERBERG H
    Plasma neurofilament light in progressive multiple sclerosis.
    Acta Neurol Scand. 2019 Oct 16. doi: 10.1111/ane.13184.
    >> Share

  48. CASTREN E, Heinonen T, Makinen K, Hamalainen P, et al
    The rate of neuropsychological assessments in multiple sclerosis has increased - A retrospective study in a Finnish central hospital.
    Acta Neurol Scand. 2019 Oct 4. doi: 10.1111/ane.13175.
    >> Share

    July 2019
  49. FERRARO D, Guicciardi C, De Biasi S, Pinti M, et al
    Plasma Neurofilaments correlate with Disability in Progressive Multiple Sclerosis patients.
    Acta Neurol Scand. 2019 Jul 27. doi: 10.1111/ane.13152.
    >> Share

  50. TOLF A, Fagius J, Carlson K, Akerfeldt T, et al
    Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation.
    Acta Neurol Scand. 2019 Jul 12. doi: 10.1111/ane.13147.
    >> Share

  51. PAKDEL M, Hedstrom A, Bidkhori M, Hadei M, et al
    Do socio-economic factors affect prevalence of multiple sclerosis in Iran?
    Acta Neurol Scand. 2019 Jul 10. doi: 10.1111/ane.13148.
    >> Share

  52. LAAKSO SM, Viitala M, Kuusisto H, Sarasoja T, et al
    Multiple sclerosis in Finland 2018- data from the national register.
    Acta Neurol Scand. 2019 Jul 4. doi: 10.1111/ane.13145.
    >> Share

  53. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
    Real-life use of oral disease-modifying treatments in Austria.
    Acta Neurol Scand. 2019;140:32-39.
    >> Share

    May 2019
  54. GASCOYNE CR, Simpson S Jr, Chen J, van der Mei I, et al
    Modifiable factors associated with depression and anxiety in multiple sclerosis.
    Acta Neurol Scand. 2019 May 23. doi: 10.1111/ane.13132.
    >> Share

  55. DE FLON P, Laurell K, Sundstrom P, Blennow K, et al
    Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.
    Acta Neurol Scand. 2019;139:462-468.
    >> Share

  56. AXELSSON M, Dubuisson N, Novakova L, Malmestrom C, et al
    Cerebrospinal fluid NCAM levels are modulated by disease-modifying therapies.
    Acta Neurol Scand. 2019;139:422-427.
    >> Share

    March 2019
  57. SEDANO MJ, Orizaola P, Gallardo E, Garcia A, et al
    A unicenter, prospective study of Guillain-Barre syndrome in Spain.
    Acta Neurol Scand. 2019 Mar 31. doi: 10.1111/ane.13092.
    >> Share

  58. CORTES-MARTINEZ A, Matias-Guiu JA, Pytel V, Montero P, et al
    What is the meaning of PASAT rejection in Multiple Sclerosis?
    Acta Neurol Scand. 2019 Mar 25. doi: 10.1111/ane.13090.
    >> Share

    February 2019
  59. ENGELS K, Schiffmann I, Weierstall R, Rahn AC, et al
    Emotions towards magnetic resonance imaging in people with multiple sclerosis.
    Acta Neurol Scand. 2019 Feb 25. doi: 10.1111/ane.13082.
    >> Share

  60. DE BERNARDO M, Vitiello L, Rosa N
    Optic nerve ultrasound measurement in multiple sclerosis.
    Acta Neurol Scand. 2019 Feb 5. doi: 10.1111/ane.13072.
    >> Share

  61. CANDELIERE MERLICCO A, Gabaldon Torres L, Villaverde Gonzalez R, Fernandez Romero I, et al
    Response to: Comment on "Transorbital ultrasonography for measuring optic nerve atrophy in multiple sclerosis".
    Acta Neurol Scand. 2019 Feb 5. doi: 10.1111/ane.13076.
    >> Share

  62. SANDROFF BM, Baird JF, Silveira SL, Motl RW, et al
    Response heterogeneity in fitness, mobility and cognition with exercise-training in MS.
    Acta Neurol Scand. 2019;139:183-191.
    >> Share

  63. DASH D, Pandey S
    Movement disorders associated with neuronal antibodies.
    Acta Neurol Scand. 2019;139:106-117.
    >> Share

    January 2019
  64. NAGAPPA M, Mahadevan A, Yashwanth G, Patil SA, et al
    Autoantibodies in Acquired Myasthenia gravis: Clinical Phenotype & Immunological correlation.
    Acta Neurol Scand. 2019 Jan 28. doi: 10.1111/ane.13071.
    >> Share

  65. RAHN AC, Kopke S, Stellmann JP, Schiffmann I, et al
    Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review.
    Acta Neurol Scand. 2019;139:18-32.
    >> Share

    November 2018
  66. PIRTTISALO AL, Soilu-Hanninen M, Sipila JOT
    Multiple sclerosis epidemiology in Finland: regional differences and high incidence.
    Acta Neurol Scand. 2018 Nov 27. doi: 10.1111/ane.13057.
    >> Share

  67. DAL-BIANCO A, Wenhoda F, Rommer PS, Weber M, et al
    Do Elevated Autoantibodies in Patients With Multiple Sclerosis Matter ?
    Acta Neurol Scand. 2018 Nov 17. doi: 10.1111/ane.13054.
    >> Share

  68. MELBYE P, Olsson A, Hansen TH, Sondergaard HB, et al
    Short-Chain Fatty Acids and Gut Microbiota in Multiple Sclerosis.
    Acta Neurol Scand. 2018 Nov 14. doi: 10.1111/ane.13045.
    >> Share

  69. STEENHOF M, Nielsen NM, Stenager E, Kyvik K, et al
    Distribution of disease courses in familial versus sporadic multiple sclerosis.
    Acta Neurol Scand. 2018 Nov 9. doi: 10.1111/ane.13044.
    >> Share

  70. DOURADO JUNIOR MET, Fernandes UT, Ramos ES, Vital ALF, et al
    Egos has a reduced capacity to predicts GBS prognosis in Northeast Brazil.
    Acta Neurol Scand. 2018;138:459-462.
    >> Share

    October 2018
  71. HOLMOY T, Rosjo E, Zetterberg H, Blennow K, et al
    Vitamin D supplementation and neurofilament light chain in multiple sclerosis.
    Acta Neurol Scand. 2018 Oct 13. doi: 10.1111/ane.13037.
    >> Share

  72. BAYART JL, Muls N, van Pesch V
    Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Acta Neurol Scand. 2018;138:352-358.
    >> Share

    August 2018
  73. WESTERBERG E, Landtblom AM, Punga AR
    Life-style factors and disease-specific differences in subgroups of Swedish Myasthenia Gravis.
    Acta Neurol Scand. 2018 Aug 28. doi: 10.1111/ane.13017.
    >> Share

  74. HAGHIGHI S, Forsmark S, Carlsson A, Nilsson MKL, et al
    Open study with (-)-OSU6162 in multiple sclerosis-related fatigue.
    Acta Neurol Scand. 2018 Aug 22. doi: 10.1111/ane.13007.
    >> Share

  75. BAUMGARTNER A, Frings L, Schiller F, Stich O, et al
    Regional neuronal activity in patients with relapsing remitting multiple sclerosis.
    Acta Neurol Scand. 2018 Aug 8. doi: 10.1111/ane.13012.
    >> Share

    July 2018
  76. MURLEY C, Yang F, Gyllensten H, Alexanderson K, et al
    Disposable income trajectories of working-aged individuals with diagnosed multiple sclerosis.
    Acta Neurol Scand. 2018 Jul 24. doi: 10.1111/ane.13001.
    >> Share

  77. ROMEO MAL, Martinelli V, Dalla Costa G, Colombo B, et al
    Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response.
    Acta Neurol Scand. 2018 Jul 22. doi: 10.1111/ane.12999.
    >> Share

  78. HAFSTEINSDOTTIR B, Olafsson E, Jakobsson F
    Incidence and outcome of Guillain-Barre syndrome in Iceland: A population-based study.
    Acta Neurol Scand. 2018 Jul 17. doi: 10.1111/ane.13000.
    >> Share

  79. GAVRILOV YV, Shkilnyuk GG, Valko PO, Stolyarov ID, et al
    Validation of the Russian version of the Fatigue Impact Scale and Fatigue Severity Scale in multiple sclerosis patients.
    Acta Neurol Scand. 2018 Jul 9. doi: 10.1111/ane.12993.
    >> Share

  80. CANDELIERE MERLICCO A, Gabaldon Torres L, Villaverde Gonzalez R, Fernandez Romero I, et al
    Transorbital ultrasonography for measuring optic nerve atrophy in multiple sclerosis.
    Acta Neurol Scand. 2018 Jul 2. doi: 10.1111/ane.12976.
    >> Share

  81. JIN S, Long Z, Wang W, Jiang B, et al
    Hyponatremia in neuromyelitis optica spectrum disorders: Literature review.
    Acta Neurol Scand. 2018;138:4-11.
    >> Share

    June 2018
  82. DALE GH, Svendsen KB, Gjelstrup MC, Christensen T, et al
    Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
    Acta Neurol Scand. 2018;137:582-588.
    >> Share

    May 2018
  83. CEA G, Martinez D, Salinas R, Vidal C, et al
    Clinical and epidemiological features of myasthenia gravis in Chilean population.
    Acta Neurol Scand. 2018 May 29. doi: 10.1111/ane.12967.
    >> Share

  84. BERNTSSON SG, Kristoffersson A, Bostrom I, Feresiadou A, et al
    Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden - Outlier or predecessor?
    Acta Neurol Scand. 2018 May 24. doi: 10.1111/ane.12963.
    >> Share

  85. SEBASTIAO E, Motl RW
    Body mass index and cardiorespiratory fitness in persons with multiple sclerosis.
    Acta Neurol Scand. 2018 May 11. doi: 10.1111/ane.12959.
    >> Share

  86. ABDOLLAHPOUR I, Nedjat S, Mansournia MA, Eckert S, et al
    Infectious exposure, antibiotic use, and multiple sclerosis: A population-based incident case-control study.
    Acta Neurol Scand. 2018 May 9. doi: 10.1111/ane.12958.
    >> Share

  87. HONG Y, Li HF, Romi F, Skeie GO, et al
    HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.
    Acta Neurol Scand. 2018 May 7. doi: 10.1111/ane.12951.
    >> Share

  88. SHU Y, Chang Y, Wu H, Li J, et al
    Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis.
    Acta Neurol Scand. 2018;137:515-522.
    >> Share

    April 2018
  89. AXELSSON M, Sjogren M, Andersen O, Blennow K, et al
    Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barre syndrome: A pilot study.
    Acta Neurol Scand. 2018 Apr 6. doi: 10.1111/ane.12927.
    >> Share

    March 2018
  90. HEYDARPOUR P, Manouchehrinia A, Beiki O, Mousavi SE, et al
    Smoking and worsening disability in multiple sclerosis: A meta-analysis.
    Acta Neurol Scand. 2018 Mar 15. doi: 10.1111/ane.12916.
    >> Share

  91. VISTBAKKA J, Sumelahti ML, Lehtimaki T, Elovaara I, et al
    Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients.
    Acta Neurol Scand. 2018 Mar 12. doi: 10.1111/ane.12921.
    >> Share

  92. RAHMANZADEH R, Weber MS, Bruck W, Navardi S, et al
    B cells in multiple sclerosis therapy-A comprehensive review.
    Acta Neurol Scand. 2018 Mar 7. doi: 10.1111/ane.12915.
    >> Share

    February 2018
  93. MANI A, Chohedri E, Ravanfar P, Mowla A, et al
    Efficacy of group cognitive rehabilitation therapy in multiple sclerosis.
    Acta Neurol Scand. 2018 Feb 7. doi: 10.1111/ane.12904.
    >> Share

  94. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
    Real-life clinical use of natalizumab and fingolimod in Austria.
    Acta Neurol Scand. 2018;137:181-187.
    >> Share

  95. AI P, Zhang X, Xie Z, Liu G, et al
    The HMGB1 is increased in CSF of patients with an Anti-NMDAR encephalitis.
    Acta Neurol Scand. 2018;137:277-282.
    >> Share

  96. NICKEL S, von dem Knesebeck O, Kofahl C
    Self-assessments and determinants of HRQoL in a German MS population.
    Acta Neurol Scand. 2018;137:174-180.
    >> Share

  97. FALIP M, Rodriguez-Bel L, Castaner S, Miro J, et al
    Musicogenic reflex seizures in epilepsy with glutamic acid decarbocylase antibodies.
    Acta Neurol Scand. 2018;137:272-276.
    >> Share

    January 2018
  98. CHANDAN S, Shukla G, Gupta A, Srivastava A, et al
    Acute-onset Restless legs syndrome in acute neurological conditions-a prospective study on patients with the Guillain-Barre syndrome and acute stroke.
    Acta Neurol Scand. 2018 Jan 22. doi: 10.1111/ane.12890.
    >> Share

  99. MESCHERIAKOVA JY, Hintzen RQ
    No excess of autoimmune diseases in multiple sclerosis families from the Netherlands.
    Acta Neurol Scand. 2018 Jan 7. doi: 10.1111/ane.12896.
    >> Share

  100. RORSMAN I, Petersen C, Nilsson PC
    Cognitive functioning following one-year natalizumab treatment: A non-randomized clinical trial.
    Acta Neurol Scand. 2018;137:117-124.
    >> Share

    December 2017
  101. OLSSON A, Oturai AB, Sondergaard HB, Sellebjerg F, et al
    Bone microarchitecture and bone mineral density in multiple sclerosis.
    Acta Neurol Scand. 2017 Dec 21. doi: 10.1111/ane.12884.
    >> Share

  102. ZECCA C, Antozzi CG, Torri Clerici V, Ferrazzini M, et al
    Severe multiple sclerosis reactivation during prolonged lymphopenia after dimethyl fumarate discontinuation.
    Acta Neurol Scand. 2017 Dec 3. doi: 10.1111/ane.12882.
    >> Share

  103. HEESEN C, Haase R, Melzig S, Poettgen J, et al
    Perceptions on the value of bodily functions in multiple sclerosis.
    Acta Neurol Scand. 2017 Dec 3. doi: 10.1111/ane.12881.
    >> Share

    November 2017
  104. IBRAHIM J, Grapperon AM, Manfredonia F, van den Bergh PY, et al
    Serial electrophysiology in Guillain-Barre syndrome: A retrospective cohort and case-by-case multicentre analysis.
    Acta Neurol Scand. 2017 Nov 21. doi: 10.1111/ane.12872.
    >> Share

  105. ZETTERBERG H
    Fluid biomarkers for microglial activation and axonal injury in multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:15-17.
    >> Share

  106. LYCKE J
    Trials of antivirals in the treatment of multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:45-48.
    >> Share

  107. CELIUS EG
    Infections in patients with multiple sclerosis: Implications for disease-modifying therapy.
    Acta Neurol Scand. 2017;136 Suppl 201:34-36.
    >> Share

  108. WEKERLE H
    Nature, nurture, and microbes: The development of multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:22-25.
    >> Share

  109. FREDERIKSEN JL, Topsoe Mailand M
    Vaccines and multiple sclerosis.
    Acta Neurol Scand. 2017;136 Suppl 201:49-51.
    >> Share

  110. WENDEL-HAGA M, Celius EG
    Is the hygiene hypothesis relevant for the risk of multiple sclerosis?
    Acta Neurol Scand. 2017;136 Suppl 201:26-30.
    >> Share

    August 2017
  111. WALLIN MT, Culpepper WJ, Maloni H, Kurtzke JF, et al
    The Gulf War era multiple sclerosis cohort: 3. Early clinical features.
    Acta Neurol Scand. 2017 Aug 22. doi: 10.1111/ane.12810.
    >> Share

    July 2017
  112. ANDERSEN O, Hildeman A, Longfils M, Tedeholm H, et al
    Diffusion tensor imaging in multiple sclerosis at different final outcomes.
    Acta Neurol Scand. 2017 Jul 25. doi: 10.1111/ane.12797.
    >> Share

  113. CAMBRON M, Hadhoum N, Duhin E, Lacour A, et al
    JCV serology in time: 3 years of follow-up.
    Acta Neurol Scand. 2017;136:54-58.
    >> Share

    June 2017
  114. GUAN Z, Shang L, Zhang W, Guo Y, et al
    A rating scale for the severity of Guillain-Barre syndrome.
    Acta Neurol Scand. 2017 Jun 14. doi: 10.1111/ane.12786.
    >> Share

  115. OTTO M, Markvardsen L, Tankisi H, Jakobsen J, et al
    The electrophysiological response to immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy.
    Acta Neurol Scand. 2017;135:656-662.
    >> Share

    May 2017
  116. MENTIS AA, Dardiotis E, Grigoriadis N, Petinaki E, et al
    Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation.
    Acta Neurol Scand. 2017 May 23. doi: 10.1111/ane.12775.
    >> Share

    April 2017
  117. MARTINELLI V, Dalla Costa G, Messina MJ, Di Maggio G, et al
    Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes.
    Acta Neurol Scand. 2017 Apr 9. doi: 10.1111/ane.12761.
    >> Share

    March 2017
  118. ELKJAER ML, Molnar T, Illes Z
    Teriflunomide for multiple sclerosis in real-world setting.
    Acta Neurol Scand. 2017 Mar 20. doi: 10.1111/ane.12755.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016